Reducing the Inflammatory Interleukins with Anti-Inflammatory and Antioxidant Effects of Propolis in Patients with Type 2 Diabetes: Double-Blind, Randomized Controlled, Clinical Trial
Mojgan Yousefi, S. Hashemipour, M. Shiri-Shahsavar, Y. Koushan, H. K. Haghighian
{"title":"Reducing the Inflammatory Interleukins with Anti-Inflammatory and Antioxidant Effects of Propolis in Patients with Type 2 Diabetes: Double-Blind, Randomized Controlled, Clinical Trial","authors":"Mojgan Yousefi, S. Hashemipour, M. Shiri-Shahsavar, Y. Koushan, H. K. Haghighian","doi":"10.5603/cd.96910","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10386,"journal":{"name":"Clinical Diabetology","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/cd.96910","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
期刊介绍：
Clinical Diabetology hereinafter referred to as ‘CD’ or ′the Journal′, is a peer-reviewed, open access journal covering broad spectrum of topics in diabetology and aiming to advance the knowledge and science of this rapidly evolving field. The Journal is the official bimonthly of the Diabetes Poland (Polish Diabetes Association) and publishes review articles, original clinical and experimental investigations in the field of diabetology, case reports, letters and editorial comments . The Journal has been published in full text English since 2016.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
